Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Schleiermacher, Gudrun" or (type exact bookEditor and editor="Schleiermacher, Gudrun")

Add to list
- Journal Article
- A1
- open access
Cell-free DNA as a diagnostic and prognostic biomarker in pediatric rhabdomyosarcoma

Nathalie S.M. Lak, Lieke M.J. van Zogchel, Lily Zappeij-Kannegieter, Ahmad Javadi, Ruben Van Paemel (UGent) , Charlotte Vandeputte, Katleen De Preter (UGent) , Bram De Wilde (UGent) , Mathieu Chicard, Yasmine Iddir, et al.

(2023) JCO PRECISION ONCOLOGY. 7.
Add to list
- Journal Article
- A1
- open access
The feasibility of using liquid biopsies as a complementary assay for copy number aberration profiling in routinely collected paediatric cancer patient samples

Ruben Van Paemel (UGent) , Charlotte Vandeputte, Lennart Raman, Jolien Van Thorre, Leen Willems (UGent) , Jo Van Dorpe (UGent) , Malaïka Van der Linden (UGent) , Jilke De Wilde (UGent) , Andries De Koker (UGent) , Björn Menten (UGent) , et al.

(2022) EUROPEAN JOURNAL OF CANCER. 160. p.12-23
Add to list
Minimally invasive classification of pediatric solid tumors using reduced representation bisulfite sequencing of cell-free DNA : a proof-of-principle study

Ruben Van Paemel (UGent) , Andries De Koker (UGent) , Charlotte Vandeputte, Lieke van Zogchel, Tim Lammens (UGent) , Genevieve Laureys (UGent) , Jo Vandesompele (UGent) , Gudrun Schleiermacher, Mathieu Chicard, Nadine Van Roy (UGent) , et al.

(2021) EPIGENETICS. 16(2). p.196-208
Add to list
- Journal Article
- A1
- open access
A G316A polymorphism in the ornithine decarboxylase gene promoter modulates MYCN-driven childhood neuroblastoma

Laura D. Gamble, Stefania Purgato, Michelle J. Henderson, Simone Di Giacomo, Amanda J. Russell, Paolo Pigini, Jayne Murray, Emanuele Valli, Giorgio Milazzo, Federico M. Giorgi, et al.

(2021) CANCERS. 13(8).
Add to list
- Journal Article
- A1
- open access
Frequency and prognostic impact of ALK amplifications and mutations in the European Neuroblastoma Study Group (SIOPEN) high-risk neuroblastoma trial (HR-NBL1)

Angela Bellini, Ulrike Pötschger, Virginie Bernard, Eve Lapouble, Sylvain Baulande, Peter F. Ambros, Nathalie Auger, Klaus Beiske, Marie Bernkopf, David R. Betts, et al.

(2021) JOURNAL OF CLINICAL ONCOLOGY. 39(30). p.3377-3390
Add to list
- Journal Article
- A1
- open access
The pitfalls and promise of liquid biopsies for diagnosing and treating solid tumors in children : a review

Ruben Van Paemel (UGent) , ROSALIE VLUG, Katleen De Preter (UGent) , Nadine Van Roy (UGent) , Franki Speleman (UGent) , Leen Willems (UGent) , Tim Lammens (UGent) , Genevieve Laureys (UGent) , Gudrun Schleiermacher, Godelieve AM Tytgat, et al.

(2020) EUROPEAN JOURNAL OF PEDIATRICS. 179(2). p.191-202
Add to list
- Conference Paper
- C3
Minimally invasive classification of pediatric solid tumors using reduced representation bisulfite sequencing of cell-free DNA

Ruben Van Paemel (UGent) , Andries De Koker (UGent) , Charlotte Vandeputte, Lieke Van Zogchel, Tim Lammens (UGent) , Genevieve Laureys (UGent) , Jo Vandesompele (UGent) , Gudrun Schleiermacher, Matthieu Chicard, Nadine Van Roy (UGent) , et al.

(2020) CLINICAL CANCER RESEARCH. 26(11 Suppl). p.93-93
Add to list
Accelerating drug development for neuroblastoma : summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma

Lucas Moreno, Giuseppe Barone, Steven G. DuBois, Jan Molenaar, Matthias Fischer, Johannes Schulte, Angelika Eggert, Gudrun Schleiermacher, Franki Speleman (UGent) , Louis Chesler, et al.

(2020) EUROPEAN JOURNAL OF CANCER. 136. p.52-68
Add to list
- Miscellaneous
- open access
Minimally invasive classification of pediatric solid tumors using reduced representation bisulfite sequencing of cell-free DNA : a proof-of-principle study

Ruben Van Paemel (UGent) , Andries De Koker (UGent) , Charlotte Vandeputte, Lieke van Zogchel, Tim Lammens (UGent) , Genevieve Laureys (UGent) , Jo Vandesompele (UGent) , Gudrun Schleiermacher, Mathieu Chicard, Nadine Van Roy (UGent) , et al.

(2019) bioRxiv.
Add to list
Risk stratification of high-risk metastatic neuroblastoma : a report from the HR-NBL-1/SIOPEN study

Daniel A Morgenstern, Ulrike Pötschger, Lucas Moreno, Vassilios Papadakis, Cormac Owens, Shifra Ash, Claudia Pasqualini, Roberto Luksch, Alberto Garaventa, Adela Canete, et al.

(2018) PEDIATRIC BLOOD & CANCER. 65(11).

Academic Bibliography

Cell-free DNA as a diagnostic and prognostic biomarker in pediatric rhabdomyosarcoma

The feasibility of using liquid biopsies as a complementary assay for copy number aberration profiling in routinely collected paediatric cancer patient samples

Minimally invasive classification of pediatric solid tumors using reduced representation bisulfite sequencing of cell-free DNA : a proof-of-principle study

A G316A polymorphism in the ornithine decarboxylase gene promoter modulates MYCN-driven childhood neuroblastoma

Frequency and prognostic impact of ALK amplifications and mutations in the European Neuroblastoma Study Group (SIOPEN) high-risk neuroblastoma trial (HR-NBL1)

The pitfalls and promise of liquid biopsies for diagnosing and treating solid tumors in children : a review

Minimally invasive classification of pediatric solid tumors using reduced representation bisulfite sequencing of cell-free DNA

Accelerating drug development for neuroblastoma : summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma

Minimally invasive classification of pediatric solid tumors using reduced representation bisulfite sequencing of cell-free DNA : a proof-of-principle study

Risk stratification of high-risk metastatic neuroblastoma : a report from the HR-NBL-1/SIOPEN study

Contents

Support

Contact